Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 16/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9935843 | 0.91 | SMN1; SMN2 (0.33) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| SCHEMBL9936382 | 0.91 | FDPS (0.43) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| SCHEMBL9936156 | 0.88 | FDPS (0.43) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| SCHEMBL9934785 | 0.88 | FDPS (0.43) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| SCHEMBL9934576 | 0.87 | FDPS (0.43) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| Sulfuric Acid SCHEMBL5169476 | 0.86 | FDPS (0.42) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| SCHEMBL9934145 | 0.85 | ALDH1A1 (0.33) | SMN1; SMN2MEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL9934327 | 0.85 | FDPS (0.38) | FDPS | |
| SCHEMBL3187868 | 0.84 | FDPS (0.41) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A | |
| Sulfuric Acid SCHEMBL5930927 | 0.84 | FDPS (0.41) | FDPSSMN1; SMN2MEN1HSP90AA1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | FDPS 4250/4885SMN1; SMN2 2527/4885MEN1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.